RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.
Characteristics of new users of aclidinium, aclidinium/formoterol, and other COPD medications in three European countries
Rebordosa Garcia, C., Rubino, A., Witzleb, AJ., Olesen, M., Plana Hortoneda, E., Aguado, J., Saigi-Morgui, N., Daoud, SZ., Lei, A., Perez-Gutthann, S., Schink, T., Kristiansen, N. S., Pottegård, A., & Rivero-Ferrer, E. (2020). Characteristics of new users of aclidinium, aclidinium/formoterol, and other COPD medications in three European countries. European Respiratory Journal, 56(Suppl 64), 2071. https://doi.org/10.1183/13993003.congress-2020.2072
